Daglipack M 10/500 Tablet ER

Overview Daglipack M 10/500 Tablet ER

Metformin/Glimepiride Extended-Release tablets (10/500mg) are a dual-action medication prescribed for managing type 2 diabetes. This combination effectively regulates elevated blood glucose, minimizing the risk of severe diabetic complications and contributing to heart health protection. Administer this medication with food, consistently at the same time each day to aid adherence. Dosage is determined by your physician and should not be altered without their explicit guidance; discontinuation may lead to uncontrolled blood sugar, potentially causing kidney impairment or vision loss. This medication is a component of a comprehensive diabetes management plan, incorporating a balanced diet, physical activity, and weight management as directed by your doctor. Commonly reported side effects encompass throat irritation, nasal stuffiness, rhinorrhea, cephalalgia, nausea, emesis, and diarrhea. Adequate hydration is recommended to counteract dehydration. Genital yeast infections may occur; diligent hygiene practices help mitigate this risk. Prior to commencing treatment, disclose any renal or hepatic dysfunction, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals require medical consultation before use. Limit alcohol consumption to reduce potential adverse reactions. Regular blood glucose monitoring is essential during treatment.

Uses of Daglipack M 10/500 Tablet ER

Managing type 2 diabetes

Major Benefits of Daglipack M 10/500 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Daglipack M 10/500 Tablet ER should be administered with a meal.

Common Side effects of Daglipack M 10/500 Tablet ER:

• Nausea
• Vomiting
• Diarrhea
• Genital fungal infection
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Urinary tract infection
• Polyuria
• Flatulence
• Skin rash
• Taste change
• Difficulty in urination
• Hypoglycemia (low blood glucose level)
• Tremors
• Dizziness
• Back pain
• Increased hematocrit
• Decreased creatinine clearance
• Dyslipidemia

How to use Daglipack M 10/500 Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Daglipack M 10/500 Extended-Release tablets should be taken with meals.

How Daglipack M 10/500 Tablet ER works:

Daglipack M 10/500 Extended-Release tablets combine dapagliflozin and metformin to manage type 2 diabetes. Dapagliflozin facilitates glucose excretion via the kidneys, while metformin reduces hepatic glucose output, slows intestinal glucose uptake, and enhances insulin sensitivity. This dual action leads to improved glycemic control.

What if you forget to take Daglipack M 10/500 Tablet ER :

Should you forget a dose of Daglipack M 10/500 Tablet ER, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.